市場調查報告書
商品編碼
1403421
女性用醫療設備市場至2030年預測:按產品類型、應用、最終用戶和地區分類的全球分析Women's Health Devices Market Forecasts to 2030 - Global Analysis By Product (Labor & Delivery, Critical Care, Contraceptives, Surgical, Diagnostics and Other Products), Type, Application, End User and By Geography |
根據 Stratistics MRC 的資料,2023年全球女性用醫療設備市場規模為 524 億美元,預計預測期內年複合成長率為 11.3%,到2030年將達到 1,101 億美元。
用於生育治療、計劃生育、孕產婦和月經健康的產品歸類為女性健康用品。這些小工具包括專門用於治療女性特有的疾病和健康問題的各種醫療設備。這些設備解決了許多女性健康問題,包括更年期、懷孕、生產和生殖健康。它還治療乳腺癌、子宮頸癌和骨盆底問題等疾病。
根據國際癌症研究機構的資料,乳癌已超過肺癌,成為女性最常被診斷的癌症類型。2020年,報告了約230萬新發乳癌病例。2020年,大約將有920萬人新診斷出癌症,440萬人將死亡。
提高對婦女健康的認知與關注
由於人們對女性健康及其相關活動的認知不斷增強,小工具的誕生是為了滿足特定的醫療需求。由於公共衛生和教育方面的努力,對這些小工具的需求也在增加。女性可以使用這些小工具追蹤健康指標的變化,這些小工具通常強調預防性健康措施並鼓勵早期療育和預防活動。這些方面推動市場擴張。
缺乏市場滲透
儘管對女性用醫療設備的需求重要且不斷成長,但與已開發國家相比,新興地區大眾對許多女性疾病的認知較低。對於影響婦女健康的疾病的許多徵兆,人們缺乏許多了解,而這些疾病可以透過適當的診斷和治療工具輕鬆治療和逆轉。這些嚴重損害了這些國家婦女的生存率。因此,這個因素可能會阻礙市場的擴張。
盛行率上升
近幾十年來,由於多種原因,包括診斷技術的技術進步以及導致引進預防性醫療保健的意識提高,婦女健康問題的總體發病率大幅增加。由於發病率顯著增加,大量患者現在患有慢性和殘疾疾病,這些疾病對他們的日常功能產生負面影響,並顯著增加了他們的死亡風險。這些都是影響市場拓展的方面。
高可維護性和複雜性
這些設備需要昂貴的定期維護和修理。由於需要專業技術人員和零件,費用可能會增加。如果設備需要維修或維護,可能會出現一段時間的停機時間。因此,預訂和醫療服務可能會受到影響。有些小工具複雜且精密,因此難以維護。這種複雜性可能會導致維修時間更長。因此,這個因素可能會阻礙市場的成長。
COVID-19 的爆發導致該行業主要參與者的收入下降。疫情期間,排卵監測儀、子宮內避孕器、月經痛管理和女性用保險套等女性用避孕器的需求下降。女性用避孕器具銷售下降的原因是對消費者流動的限制和嚴格的社交距離規則阻礙了社交聚會。
預計在預測期內,慢性病領域將是最大的。
預計慢性病細分市場將成為預測期內最大的細分市場。飲食的改變、缺乏運動和生活方式的改變日益增加女性糖尿病、癌症和心臟病等慢性疾病的盛行率。影響女性最常見的慢性疾病是癌症。由於女性肺癌、卵巢、結腸癌和乳腺癌等癌症發生率的增加,這一領域急劇成長。
預計醫院和診所產業在預測期內將經歷最高的年複合成長率。
預計醫院和診所產業在預測期內將經歷最高的年複合成長率。這可能只是由於人們越來越傾向於使用醫院來治療大多數疾病。該行業成長的主要驅動力是公立和私立醫院使用量的增加,私人診所的成長,醫院專門婦女病房的可用性,醫院診斷和治療基礎設施的加強及其發展。
由於女性人口眾多,預計北美在預測期內將佔據最大的市場佔有率。由於婦女醫療保健方面的高支出和對高科技設備的高需求,預計該地區將具有優勢。該地區的主要市場參與者預計將繼續增加在研發、臨床研究和引進創新健康設備方面的支出,進一步增加市場需求。
預計亞太地區在預測期內將維持最高的年複合成長率。由於政府活性化力度促進該國性別平等,女性人口迅速增加。此外,女性勞動參與率的上升也增加了女性的可支配所得。女性族群中癌症、糖尿病、心血管疾病和呼吸系統疾病等各種慢性疾病的盛行率上升預計將促進市場成長。
According to Stratistics MRC, the Global Women's Health Devices Market is accounted for $52.4 billion in 2023 and is expected to reach $110.1 billion by 2030 growing at a CAGR of 11.3% during the forecast period. Products for fertility, family planning, and maternal and menstrual health are classified as women's health gadgets. These gadgets include a broad variety of medical equipment made especially to treat illnesses or health problems that are exclusive to women. These devices address a number of women's health issues, including menopause, pregnancy, delivery, and reproductive health. They also address illnesses including breast and cervical cancer, pelvic floor problems, and more.
According to the International Agency for Research on Cancer, the female breast cancer has become the most diagnosed type of cancer by surpassing the lungs cancer. Around 2.3 million new cases of breast cancer were reported in 2020. Around 9.2 million new cases of cancer and 4.4 million cancer deaths in female were reported in 2020.
The creation of gadgets that meet particular medical demands has been aided by increased awareness of women's health concerns and activities cantered around them. The need for these gadgets has also grown as a result of public health initiatives and educational initiatives. Women may follow changes in their health markers using these gadgets, which generally highlight preventative health measures and encourage early intervention and preventive activities. These are the aspects fostering the market's expansion.
Despite a crucial and increasing demand for women's health equipment, awareness of many women's diseases is poor among the general public in emerging regions, as opposed to industrialized countries. A great deal of knowledge is lacking on the many signs of disorders affecting women's health that are readily treated or resolved with the right diagnosis and treatment tools. These seriously impair women's survival rates in these nations. Therefore, this factor might impede market expansion.
The general incidence of women's health problems has risen considerably in recent decades as a result of numerous reasons, including technical advances in diagnostic technologies and improved awareness, which has led to the adoption of preventative care. Due to the notable increase in incidence, there is now a substantial patient population with chronic and crippling illnesses that have a negative impact on daily functioning and significantly increase the risk of death. These are the aspects affecting the market's expansion.
These gadgets require pricey routine upkeep and repairs. Higher expenses may result from the demand for specialized technicians or parts. There may be a period of inactivity when equipment needs to be serviced or maintained. This might affect arranged appointments or healthcare services. Some gadgets are difficult to maintain because they are complicated and sophisticated. Lengthier repair durations may also result from this complexity. As a result, this factor may prevent market growth.
The COVID-19 epidemic caused a reduction in income for major participants in the industry. During the pandemic, there was a decrease in the demand for female contraceptive goods, including ovulation monitors, intrauterine devices, menstrual pain management, and female condoms. Sales of female contraceptive devices fell as a result of consumer mobility constraints and stringent social distance rules that discouraged socializing.
The chronic diseases segment is expected to be the largest during the forecast period. The incidence of chronic illnesses, including diabetes, cancer, heart disease, and other conditions, is increasing among women due to dietary changes, physical inactivity, and altered lifestyles. The most common chronic illness affecting women is cancer. This sector has grown dramatically as a result of the increasing incidence of lung cancer, ovarian cancer, colon cancer, and breast cancer among women.
The hospitals & clinics segment is expected to have the highest CAGR during the forecast period. This may be attributed only to the population's growing inclination towards using hospitals for treatment of most illnesses. The main drivers of the segment's growth have been the increased use of both public and private hospitals, the growth of private clinics, the availability of specialized wards for women at hospitals, and the strength and development of the hospital's infrastructure for diagnosis and treatment.
North America is projected to hold the largest market share during the forecast period owing to the presence of huge female population in the region. High spending on women's health care and a correspondingly high demand for high-tech devices are expected to contribute to the region's dominance. It is anticipated that the leading market players in the area will continue to increase their spending in R&D, clinical studies, and the introduction of innovative health gadgets, which will further increase demand in the market.
Asia Pacific is projected to hold the highest CAGR over the forecast period. The increased government initiatives to promote gender equality in the nation have resulted in a surge in the women population. Moreover, the rising participation of women in the workforce is resulting in the increased disposable income of the women. The rising prevalence of various chronic diseases such as cancer, diabetes, cardiovascular diseases, and respiratory disorders among the women population is expected to augment the growth of the market.
Some of the key players in Women's Health Devices market include Koninklijke Philips, Siemens AG, Prestige Consumer Healthcare, Inc., Caldera Medical, MedGyn Products, Medline Industries, Abbott Laboratories, Carestream Health, GE Healthcare, F. Hoffmann-La Roche, Hologic, CooperSurgical, Inc. , Innovative Health Diagnostic and BioSkryb Genomics.
In December 2022, CooperSurgical, Inc. partnered with Ostro to launch a new consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard. Paragard is an FDA-approved intrauterine device that prevents pregnancy up to 10 years.
In October 2022, BioSkryb Genomics signed a multi-year agreement with Cooper Genomics to license BioSkryb's proprietary genomic amplification technology. Cooper Genomics will utilize BioSkryb technology to enhance its preimplantation genetic testing (PGT) capabilities.